| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/1535370215593826 |
| P8608 | Fatcat ID | release_ran5pylbqjfxbio42cpk5teyj4 |
| P932 | PMC publication ID | 4935288 |
| P698 | PubMed publication ID | 26142116 |
| P5875 | ResearchGate publication ID | 279726714 |
| P50 | author | Leonardo Punzi | Q56419705 |
| Andrea Doria | Q38544117 | ||
| P2093 | author name string | Roberto Luisetto | |
| Anna Ghirardello | |||
| Nicola Bassi | |||
| Mariele Gatto | |||
| Felipe L de Oliveira | |||
| P2860 | cites work | Expression of galectin-3 modulates T-cell growth and apoptosis | Q24309392 |
| Galectin-3 regulates myofibroblast activation and hepatic fibrosis | Q24546358 | ||
| Rheumatoid arthritis susceptibility genes: An overview | Q26824670 | ||
| Nuclear transport of galectin-3 and its therapeutic implications | Q26824889 | ||
| Basic and translational concepts of immune-mediated glomerular diseases | Q26995440 | ||
| Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets | Q27025680 | ||
| Multiple sclerosis | Q28299151 | ||
| Immune-mediated beta-cell destruction in vitro and in vivo-A pivotal role for galectin-3 | Q28574963 | ||
| Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages | Q29547871 | ||
| Interferon and granulopoiesis signatures in systemic lupus erythematosus blood | Q29615064 | ||
| Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self | Q29619194 | ||
| Autoantibodies in atopic dermatitis | Q30982963 | ||
| Anti-Galectin-3 IgG autoantibodies in patients with Crohn's disease characterized by means of phage display peptide libraries | Q31031256 | ||
| Identification of autoantibodies associated with systemic lupus erythematosus | Q31087661 | ||
| Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation | Q32058522 | ||
| The pathology of T cells in systemic lupus erythematosus | Q33598213 | ||
| Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. | Q33731760 | ||
| Lack of galectin-3 disturbs mesenteric lymph node homeostasis and B cell niches in the course of Schistosoma mansoni infection. | Q33900663 | ||
| Immunoglobulin responses at the mucosal interface. | Q34025272 | ||
| Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis | Q40016270 | ||
| The constitutive expression of galectin-3 is downregulated in the intestinal epithelia of Crohn's disease patients, and tumour necrosis factor alpha decreases the level of galectin-3-specific mRNA in HCT-8 cells. | Q40735267 | ||
| Galectin-3 down-regulates IL-5 gene expression on different cell types | Q41029757 | ||
| Galectin-3 binding protein links circulating microparticles with electron dense glomerular deposits in lupus nephritis. | Q41120532 | ||
| Lack of galectin-3 up-regulates IgA expression by peritoneal B1 lymphocytes during B cell differentiation | Q41205968 | ||
| Dissecting the immune cell mayhem that drives lupus pathogenesis | Q41580653 | ||
| Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways | Q42077799 | ||
| Galectin-3 negatively regulates dendritic cell production of IL-23/IL-17-axis cytokines in infection by Histoplasma capsulatum. | Q42272758 | ||
| GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death | Q42324031 | ||
| Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti-Thy1.1 antibodies | Q42474421 | ||
| Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis | Q44361867 | ||
| CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis | Q44695762 | ||
| Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced arthritis. | Q45859504 | ||
| Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis | Q45876518 | ||
| Discerning the kinetics of autoimmune manifestations in a model of Sjögren's syndrome | Q45882170 | ||
| Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD? | Q46095235 | ||
| Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice. | Q46323175 | ||
| Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice. | Q46471398 | ||
| Regulation of galectin-3 function in mucosal fibroblasts: potential role in mucosal inflammation | Q46705680 | ||
| Spontaneous formation of germinal centers in autoimmune mice. | Q47574161 | ||
| Serum galectin-3 level in systemic sclerosis | Q47866004 | ||
| Sciatic nerve regeneration is accelerated in galectin-3 knockout mice | Q47877781 | ||
| The involvement of the spleen during chronic phase of Schistosoma mansoni infection in galectin-3-/- mice. | Q50507379 | ||
| Galectin-3 mediates IL-4-induced survival and differentiation of B cells: functional cross-talk and implications during Trypanosoma cruzi infection. | Q51011747 | ||
| Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study. | Q51188060 | ||
| Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis. | Q53141150 | ||
| Psoriasis in humans is associated with down-regulation of galectins in dendritic cells. | Q54327668 | ||
| Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro. | Q54460380 | ||
| Prognosis of scleroderma renal crisis: a long-term observational study | Q61649506 | ||
| Lack of galectin-3 speeds Wallerian degeneration by altering TLR and pro-inflammatory cytokine expressions in injured sciatic nerve | Q61695764 | ||
| Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice | Q61903452 | ||
| Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosus | Q62620530 | ||
| Glycophenotype of psoriatic skin | Q62621726 | ||
| Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis | Q70146489 | ||
| Galectin-3/MAC-2 in experimental allergic encephalomyelitis | Q73320823 | ||
| Localization of galectin-3 in normal and diseased pancreatic tissue | Q74372136 | ||
| Kinetics of mobilization and differentiation of lymphohematopoietic cells during experimental murine schistosomiasis in galectin-3 -/- mice | Q80211016 | ||
| Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia | Q81613971 | ||
| Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis | Q83328154 | ||
| Galectin-3 regulates peritoneal B1-cell differentiation into plasma cells | Q84441243 | ||
| British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis | Q84561367 | ||
| Disturbed Th17/Treg balance in patients with rheumatoid arthritis | Q84644585 | ||
| IL-17 contributes to autoimmune hepatitis | Q84749635 | ||
| Natural history of allergic sensitization in infants with early-onset atopic dermatitis: results from ORCA Study | Q85679868 | ||
| Histopathological environment besides the focus score in Sjögren's syndrome | Q85706432 | ||
| Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus | Q85759970 | ||
| Increased levels of serum galectin-3 in patients with primary Sjögren's syndrome: associated with interstitial lung disease | Q88188489 | ||
| Phagocytic properties of microglia in vitro: implications for a role in multiple sclerosis and EAE. | Q34309554 | ||
| Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage | Q34443260 | ||
| Galectin-3: an open-ended story | Q34494555 | ||
| Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis | Q34501897 | ||
| Clinical implications of autoantibody screening in patients with autoimmune myositis | Q34537296 | ||
| Novel aspects of Sjögren's syndrome in 2012. | Q34650103 | ||
| The clinical features, diagnosis and classification of dermatomyositis. | Q34659254 | ||
| The regulation of inflammation by galectin-3. | Q34991925 | ||
| Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity | Q35088408 | ||
| In-/off-label use of biologic therapy in systemic lupus erythematosus | Q35094536 | ||
| An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas | Q35096060 | ||
| The etiology of glomerulonephritis: roles of infection and autoimmunity | Q35118856 | ||
| Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function. | Q35302064 | ||
| Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survival | Q35392528 | ||
| Tolerogenic function of Blimp-1 in dendritic cells | Q35441479 | ||
| Signatures of human regulatory T cells: an encounter with old friends and new players | Q35606024 | ||
| Immune mechanisms of Concanavalin A model of autoimmune hepatitis | Q35670435 | ||
| Molecular mechanisms governing thymocyte migration: combined role of chemokines and extracellular matrix | Q35691006 | ||
| Soluble galectin-3 is a strong, colonic epithelial-cell-derived, lamina propria fibroblast-stimulating factor | Q35761202 | ||
| Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo | Q35780859 | ||
| Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. | Q35809897 | ||
| Galectins as self/non-self recognition receptors in innate and adaptive immunity: an unresolved paradox. | Q36093631 | ||
| Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus | Q36102468 | ||
| Galectin-3 modulates immune and inflammatory responses during helminthic infection: impact of galectin-3 deficiency on the functions of dendritic cells | Q36313888 | ||
| Roles of galectin-3 in immune responses. | Q36366397 | ||
| Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice | Q36370602 | ||
| Lack of galectin-1 or galectin-3 alters B cell deletion and anergy in an autoantibody transgene model | Q36900466 | ||
| Roles of galectins in infection | Q37137327 | ||
| Galectin-3 is critical for the development of the allergic inflammatory response in a mouse model of atopic dermatitis | Q37150796 | ||
| Galectin-3 modulates Th17 responses by regulating dendritic cell cytokines | Q37218244 | ||
| Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. | Q37298535 | ||
| Galectin-3 regulates T-cell functions | Q37548637 | ||
| Dysregulation of germinal centres in autoimmune disease. | Q37638196 | ||
| Cytokines and effector T cell subsets causing autoimmune CNS disease | Q37863274 | ||
| The pathology and immunology of atopic dermatitis | Q37921834 | ||
| Cytokine-based therapy in psoriasis | Q37994612 | ||
| Insight into Crohn's disease pathomorphology | Q38000028 | ||
| Oligodendrocytes and the early multiple sclerosis lesion | Q38029278 | ||
| Emerging and critical issues in the pathogenesis of lupus | Q38045660 | ||
| IgA production and tonsillar focal infection in IgA nephropathy | Q38069909 | ||
| Serpins, immunity and autoimmunity: old molecules, new functions | Q38074594 | ||
| Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature | Q38097748 | ||
| Autoantibodies in polymyositis and dermatomyositis | Q38099556 | ||
| Treg cells in rheumatoid arthritis: an update | Q38124277 | ||
| Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and β-cell apoptosis | Q38134106 | ||
| Importance of regulatory T cells in the pathogenesis of psoriasis: review of the literature. | Q38139752 | ||
| Galectin-3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure | Q38148873 | ||
| Research gaps in psoriasis: opportunities for future studies. | Q38152571 | ||
| Intracellular galectins in cancer cells: potential new targets for therapy (Review). | Q38180976 | ||
| Immune modulation in humans: implications for type 1 diabetes mellitus. | Q38182297 | ||
| Pathology of systemic lupus erythematosus: the challenges ahead. | Q38185348 | ||
| Microglial phagocytosis of live neurons | Q38197408 | ||
| Dermatomyositis, polymyositis and immune-mediated necrotising myopathies | Q38218417 | ||
| Role of galectin-3 in the initial control of Leishmania infection | Q38221174 | ||
| Targeting apoptosis in autoimmune hepatitis | Q38231217 | ||
| The effect of cell death in the initiation of lupus nephritis. | Q38231647 | ||
| Functions of galectin-3 and its role in fibrotic diseases | Q38246458 | ||
| Therapy of myositis: biological and physical | Q38246832 | ||
| Multiple sclerosis and the role of immune cells. | Q38254152 | ||
| T cell mediated autoimmune glomerular disease in mice | Q38264764 | ||
| Galectin-3 modulates carbohydrate-dependent thymocyte interactions with the thymic microenvironment. | Q38289730 | ||
| Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes | Q38301765 | ||
| Galectin-3 gene (LGALS3) +292C allele is a genetic predisposition factor for rheumatoid arthritis in Taiwan. | Q38336010 | ||
| Up-regulation of galectin-3 and its ligands by Trypanosoma cruzi infection with modulation of adhesion and migration of murine dendritic cells. | Q38343204 | ||
| Immunoglobulin A nephropathy: current progress and future directions | Q38386988 | ||
| Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis | Q38497448 | ||
| Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion | Q40010233 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 1019-1028 | |
| P577 | publication date | 2015-07-03 | |
| P1433 | published in | Experimental Biology and Medicine | Q15716535 |
| P1476 | title | Galectin-3 in autoimmunity and autoimmune diseases | |
| P478 | volume | 240 |
| Q91736618 | Angiostrongylus cantonensis Galectin-1 interacts with Annexin A2 to impair the viability of macrophages via activating JNK pathway |
| Q47718174 | Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction |
| Q54697325 | Clinical significance of galectin-3 in patients with adult acute myeloid leukemia: a retrospective cohort study with long-term follow-up and formulation of risk scoring system. |
| Q36708065 | Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens |
| Q47547850 | Dissecting the Structure-Activity Relationship of Galectin-Ligand Interactions |
| Q98177367 | Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions |
| Q99240850 | Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction |
| Q64949910 | Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice. |
| Q92312918 | Galectin 3: an extraordinary multifunctional protein in dermatology. Current knowledge and perspectives |
| Q48270428 | Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives |
| Q64094882 | Galectin-3 Inhibits Paracoccidioides brasiliensis Growth and Impacts Paracoccidioidomycosis through Multiple Mechanisms |
| Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
| Q47329197 | Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). |
| Q64097454 | Galectin-3 as a prognostic biomarker for diabetic nephropathy |
| Q50126684 | Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus |
| Q90640127 | Galectin-3 orchestrates the histology of mesentery and protects liver during lupus-like syndrome induced by pristane |
| Q57157917 | Galectin-3-Mediated Glial Crosstalk Drives Oligodendrocyte Differentiation and (Re)myelination |
| Q52804420 | Immunoglobulin E-Mediated Autoimmunity. |
| Q57000023 | Investigation of Gal-3 Expression Pattern in Serum and Cerebrospinal Fluid of Patients Suffering From Neurodegenerative Disorders |
| Q48271668 | Lactosamine-Based Derivatives as Tools to Delineate the Biological Functions of Galectins: Application to Skin Tissue Repair |
| Q89965075 | Overexpression of Galectin 3 in Pancreatic β Cells Amplifies β-Cell Apoptosis and Islet Inflammation in Type-2 Diabetes in Mice |
| Q37339791 | Prognostic value of plasma galectin-3 levels after aneurysmal subarachnoid hemorrhage |
| Q99565582 | Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling |
| Q38689543 | Retrospective Proteomic Screening of 100 Breast Cancer Tissues. |
| Q47302001 | Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein can reflect systemic lupus erythematosus activity. |
| Q41449179 | Serum galectin-3 levels and delirium among postpartum intensive care unit women. |
| Q50895945 | Serum galectin-3, but not galectin-1, levels are elevated in schizophrenia: implications for the role of inflammation. |
| Q33760199 | The Many Roles of Galectin-3, a Multifaceted Molecule, in Innate Immune Responses against Pathogens. |
| Q92152673 | The Phenotype and Secretory Activity of Adipose-Derived Mesenchymal Stem Cells (ASCs) of Patients with Rheumatic Diseases |
Search more.